BioClinica, Inc. has acquired Synowledge, expanding its services into the drug safety and regulatory outsourcing market. Synowledge specializes in pharmacovigilance, regulatory affairs and information technology services to support biopharma companies with recording, analyzing and reporting adverse drug events. Synowledge is headquartered in Miami, FL and employs a global workforce of more than 500.   “This acquisition extends BioClinica’s solutions into an important new area for our customers...